Cargando…

Lots of autoantibodies equal lupus?

Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For systemic lupus erythematosus (SLE), those to RNA-binding proteins, to phospholipids, and to double-stranded DNA, in particular, have been found in sera of SLE patients years before the diagnosis was made....

Descripción completa

Detalles Bibliográficos
Autores principales: Aringer, Martin, Vital, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672808/
https://www.ncbi.nlm.nih.gov/pubmed/23347779
http://dx.doi.org/10.1186/ar4126
_version_ 1782272181071249408
author Aringer, Martin
Vital, Edward
author_facet Aringer, Martin
Vital, Edward
author_sort Aringer, Martin
collection PubMed
description Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For systemic lupus erythematosus (SLE), those to RNA-binding proteins, to phospholipids, and to double-stranded DNA, in particular, have been found in sera of SLE patients years before the diagnosis was made. New data now show in an unbiased way that, in patients with early SLE, no single antibody class or specificity is associated with progression to SLE. Rather, an increasing number of autoantibody specificities, such as to thyroid antigens, was observed in patients progressing. This points to more generalized B cell autoreactivity during progression to SLE, underlying lupus disease manifestations.
format Online
Article
Text
id pubmed-3672808
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36728082013-07-22 Lots of autoantibodies equal lupus? Aringer, Martin Vital, Edward Arthritis Res Ther Editorial Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For systemic lupus erythematosus (SLE), those to RNA-binding proteins, to phospholipids, and to double-stranded DNA, in particular, have been found in sera of SLE patients years before the diagnosis was made. New data now show in an unbiased way that, in patients with early SLE, no single antibody class or specificity is associated with progression to SLE. Rather, an increasing number of autoantibody specificities, such as to thyroid antigens, was observed in patients progressing. This points to more generalized B cell autoreactivity during progression to SLE, underlying lupus disease manifestations. BioMed Central 2013 2013-01-22 /pmc/articles/PMC3672808/ /pubmed/23347779 http://dx.doi.org/10.1186/ar4126 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Editorial
Aringer, Martin
Vital, Edward
Lots of autoantibodies equal lupus?
title Lots of autoantibodies equal lupus?
title_full Lots of autoantibodies equal lupus?
title_fullStr Lots of autoantibodies equal lupus?
title_full_unstemmed Lots of autoantibodies equal lupus?
title_short Lots of autoantibodies equal lupus?
title_sort lots of autoantibodies equal lupus?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672808/
https://www.ncbi.nlm.nih.gov/pubmed/23347779
http://dx.doi.org/10.1186/ar4126
work_keys_str_mv AT aringermartin lotsofautoantibodiesequallupus
AT vitaledward lotsofautoantibodiesequallupus